Linda Erlandson
Overview
Explore the profile of Linda Erlandson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez V, Anderson P, Litzow M, Erlandson L, Trotz B, Arndt C, et al.
Leuk Lymphoma
. 2006 Sep;
47(8):1583-92.
PMID: 16966270
In four patients, aged 15 - 20 years, with high-risk acute myeloid leukemia (AML), high-dose samarium 153-labelled ethylenediaminetetramethylenephosphonate (153Sm-EDTMP) was used for targeted marrow irradiation before preparative chemotherapy conditioning regimens...
2.
Anderson P, Wiseman G, Erlandson L, Rodriguez V, Trotz B, Dubansky S, et al.
Clin Cancer Res
. 2005 Oct;
11(19 Pt 1):6895-900.
PMID: 16203780
Osteoblastic metastases and osteosarcoma can avidly concentrate bone-seeking radiopharmaceuticals. We sought to increase effectiveness of high-dose (153)Samarium ethylenediaminetetramethylenephosphonate (153Sm-EDTMP, Quadramet) on osteosarcomas using a radiosensitizer, gemcitabine. Fourteen patients with osteoblastic...
3.
Rodriguez V, Erlandson L, Arndt C, Wiseman G, Anderson P
Pediatr Transplant
. 2005 Jan;
9(1):122-6.
PMID: 15667625
We report the case of a 15-yr-old girl who developed secondary acute myelogenous leukemia (AML) 4 yr after completion of therapy for metastatic Ewing sarcoma (primary right acetabulum with metastatic...